The Serum Institute of India

The Serum Institute of India has pledged more than 1 billion COVID-19 vaccine doses to developing nations. (Getty)

The Serum Institute of India
: AstraZeneca, Novavax, Codagenix, Bill & Melinda Gates Foundation, CEPI, Gavi

As a range of drugmakers rush to approvals for their COVID-19 vaccine, big-money supply deals and logistical hurdles have left developing nations concerned about access to potential winners. In few places is that concern larger than in India, the second most populous nation on Earth, and a vaccines giant has stepped into ensure its home country will get those shots. 

As part of massive pacts with British drugmaker AstraZeneca and a coalition of global nonprofits, the Serum Institute of India (SII) will create access to more than 1 billion doses of licensed COVID-19 vaccines to low- and middle-income countries, including in India itself. 

In late September, SII pledged to make an additional 100 million COVID shot doses available in 2021 as part of an expanded distribution effort with Gavi, the Vaccines Alliance, and the Bill & Melinda Gates Foundation.  As part of their ramped-up manufacturing pact, the Gates Foundation will plug an additional $150 million into boosting SII and Gavi's production capacity to provide shots at a maximum of $3 per dose, bringing its total commitment to $300 million. 

RELATED: Indian vaccine giant pledges 100M more coronavirus shots as part of Gates-funded troika

The Serum Institute of India